Is Amazon serious about getting into pharmacy? This analyst isn't so sure - MarketWatch
Rite Aid Corporation (RAD) Stock Will Disappear. The End Is Near.
Stocks fall Thursday ending holiday week lower; Twitter sheds 1.7% after Musk bid - MarketWatch
Keysight and Charles River shares plunge, Palo Alto Networks' stock rallies, and more big movers - MarketWatch
Matterport Announces Record Second Quarter Earnings. Solid News : r/Mttr
Match settles lawsuit with former Tinder employees for $441 million - MarketWatch
Rite Aid stock dives after Deutsche Bank slashed target to $1, warns of a 'dramatic negative inflection point' - MarketWatch
Gold Hits Record High - MarketWatch
Rite Aid stock sinks after drugstore chain warns of losses related to generics' strength - MarketWatch
Dig a little, and you'll find better stocks than the tech superstars, says Jefferies - MarketWatch
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market - MarketWatch
This Electric Vehicle Radiator market research study provides an analysis of the industry, as well as the market structure and its categorization, to help obtain a clear understanding of the sector. -
RAD Stock Forecast, Price & News (Rite Aid)
Get Ready for the Rally in Rite Aid Corporation (RAD) Stock
Nasdaq books longest streak of record closes since 1998 as Boeing CEO's exit lifts Dow - MarketWatch
DJ Khaled, Kevin Smith and other celebs attract guys to a new-look Weight Watchers - MarketWatch
RAD Web Solutions (@radwebsolution) / Twitter
The S&P 500 sank 5% in a very bad week for stocks. These 20 lost as much as 24%. - MarketWatch
15 stocks that have fallen at least 33% but by these measures are still standouts in their sectors - MarketWatch
Traders made money 'selling the rip' in stocks last year. Why it might work again in 2023. - MarketWatch
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market - MarketWatch
Best stock picks for 2023: Here are Wall Street analysts' favored choices - MarketWatch
Intel officially joins fight with Nvidia and AMD, but results could be a long time coming - MarketWatch
Bio-Rad Laboratories in Talks to Combine With Qiagen - WSJ
Options Traders React to Monster Rite Aid Rally
